NFKB1 and chronic obstructive pulmonary disease: In short, our study demonstrated that YJT provides a protective effect against LPS- and CS-induced COPD in a mouse model by reducing inflammatory responses and airway remodeling, effects that may be related to suppression of the NF-κB pathway.